Not Yet RecruitingNot Applicable

Treatment of Tinnitus With Noninvasive Neuromodulation and Listening Therapy

United States30 participantsStarted 2025-01-15

Plain-language summary

The goal of this study is to use non-invasive transcranial direct current stimulation (tDCS) combined with active listening therapy to treat tinnitus and hyperacusis and related conditions.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * chronic tinnitus and or hyperacusis (\> 8 months) * adults (18-80 years old) Exclusion Criteria: * implanted metal or devices including cochlear implants, * bullet wounds, head/neck tattoo, * metal in the eyes, * other diagnosed neurological disorders (e.g., stroke, Parkinson's, dementia, brain tumors), * head trauma or brain surgery, psychiatric disorders, * personal or family history of epilepsy, other seizure disorders * Individuals with a history of Meniere's Disease, pulsatile tinnitus, otosclerosis, and * chronic headaches. * conductive hearing loss, or * fluctuating hearing thresholds * pure tone averages \>70dB HL

What they're measuring

Mean change in tinnitus severity and annoyance on the tinnitus hearing survey (THS)

Timeframe: through study completion, an average of 1 year

Mean change in the Sound Tolerance Questionnaire ratings

Timeframe: through study completion, an average of 1 year

mean change on the Tinnitus Functional Index (TFI) scores

Timeframe: through study completion, an average of 1 year

mean change on the Tinnitus Primary Function Questionnaire (TPFQ)

Timeframe: through study completion, an average of 1 year

Mean change in tinnitus and hyperacusis ratings on the Visual Analog Scale

Timeframe: through study completion, an average of 1 year

Trial details

NCT IDNCT04934371

SponsorUniversity of Arizona

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-06-30

Contact for this trial

Aneta Kielar, PhD

520-621-5105 akielar@email.arizona.edu

View on ClinicalTrials.gov More Tinnitus, Subjective trials

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Mean change in tinnitus severity and annoyance on the tinnitus hearing survey (THS)

Timeframe: through study completion, an average of 1 year

Mean change in the Sound Tolerance Questionnaire ratings

Timeframe: through study completion, an average of 1 year

mean change on the Tinnitus Functional Index (TFI) scores

Timeframe: through study completion, an average of 1 year

mean change on the Tinnitus Primary Function Questionnaire (TPFQ)

Timeframe: through study completion, an average of 1 year

Mean change in tinnitus and hyperacusis ratings on the Visual Analog Scale

Timeframe: through study completion, an average of 1 year